Protein Alternatives

Innovating in cancer diagnostics and therapeutics

WELCOME TO PROALT

A biotechnological company developing innovative diagnostic assays for early detection of cancer and unique therapeutic antibodies against novel targets for the efficient treatment of metastatic cancers

SARS-COV-2 RECOMBINANT ANTIGENS AND DETECTION ANTIBODIES

ProAlt has designed and expressed a panel of SARS-CoV-2 recombinant antigens and an anti-human detection antibody that are available to users in the diagnostic field. Contact us to find out more about these reagents

OUR BUSINESS AREAS

THERAPEUTIC
ANTIBODIES
IN CANCER

LEARN MORE

DIAGNOSTIC
ASSAYS
IN CANCER

LEARN MORE

CUSTOM
TAILORED
SERVICES

LEARN MORE

RESEARCH
USE
PRODUCTS

LEARN MORE

Funding Institutions